NUS Links:
Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) and provides a potential target for dendritic cell vaccine therapy. This phase 1 clinical study led by Prof Goh Boon Cher and A/Prof Herbert Schwarz indicates that a novel type of dendritic cells pulsed with EBV nuclear antigen LMP2 are safe and exhibits promising efficacy when administered following chemotherapy in patients with locally recurrent or metastatic NPC.
Link to website: https://bit.ly/30fD4Gg
We are pleased to share that Prof. Goh Boon Cher and A/Prof. Wang Lingzhi have published a new edited volume …
Acute myeloid leukaemia (AML) is a fast-growing blood cancer that often becomes resistant to standard treatments. This resistance is linked …
Treatment of relapsed/refractory non-Hodgkin’s lymphoma (R/R-NHL) remains one of the most difficult challenges in haematologic malignancies, with many patients exhausting …